Pre-procedural time spent in atrial fibrillation using intermittent ECG monitoring is associated with arrhythmia recurrence after ablation: the ISOLATION cohort study

EP Europace Journal

11 March 2026
Organised by: Logo
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY Atrial Fibrillation (AF)

Abstract

AbstractAims

Atrial fibrillation (AF) is conventionally classified as paroxysmal or persistent. AF burden might better reflect response to rhythm-control interventions. This study evaluated the association between estimated pre-procedural time spent in AF and recurrences after AF ablation, compared with conventional AF classification.

Methods and results

In patients scheduled for AF ablation, clinical characteristics were collected before ablation, and 60-second single-lead ECGs were recorded three times daily (with additional symptom-triggered recordings) for four weeks. Pre-procedural time spent in AF was estimated as the number of days with detected AF divided by total monitoring days. The primary endpoint was AF recurrence between 3 and 12 months post-ablation. Of 302 patients (mean age 64 ± 9 years; 33% female), 201 (67%) had paroxysmal AF and 101 (33%) had persistent AF. After 12 months, recurrence rates were higher in persistent than in paroxysmal AF (37.6% vs. 24.4%, P & 0.01) and in patients with a higher (>32%) vs. lower (≤32%) percentage of time spent in AF (36.4% vs. 24.0%, P < 0.01). Notably, paroxysmal AF patients with a higher percentage of time in AF had recurrence rates comparable to those of patients with persistent AF. Pre-procedural percentage of time in AF independently predicted arrhythmia recurrence at 12-month follow-up (HR: 1.06; 95% CI: 1.0–1.1; P & 0.025).

Conclusion

A higher pre-procedural percentage of time spent in AF derived from 60-second single-lead ECGs is independently associated with atrial arrhythmia recurrence after ablation. Assessing the percentage of pre-procedural time spent in AF might help identify paroxysmal AF patients with a high AF recurrence risk in future studies.

Contributors

Ulrich Schotten
Ulrich Schotten

Author

Cardiovascular Research Institute Maastricht (CARIM) Maastricht , Netherlands (The)

Dominique V M Verhaert
Dominique V M Verhaert

Author

Maastricht University Medical Centre (MUMC) Maastricht , Netherlands (The)

Ozan F Özgül
Ozan F Özgül

Author

Cardiovascular Research Institute Maastricht (CARIM) Maastricht , Netherlands (The)

Emma Sandgren
Emma Sandgren

Author

Karolinska Institutet Danderyd Hospital Stockholm , Sweden

Robin Nijveldt
Robin Nijveldt

Author

University Medical Center Utrecht Utrecht , Netherlands (The)

ESC 365 is supported by